These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 1746000)

  • 41. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin.
    Reilly TM; Knabb RM; Hassell SM; Bozarth JM; Forsythe MS; Mayo MC; Racanelli AL; Mousa SA
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):513-7. PubMed ID: 1450317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
    Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.
    Bouton MC; Jandrot-Perrus M; Moog S; Cazenave JP; Guillin MC; Lanza F
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):635-41. PubMed ID: 7832783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of thrombin inhibitors on thrombin-induced platelet release and aggregation.
    Knupp CL
    Thromb Res; 1988 Jan; 49(1):23-36. PubMed ID: 3347926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
    Hortin GL; Tollefsen DM; Benutto BM
    J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation.
    Liu L; Freedman J; Hornstein A; Fenton JW; Song Y; Ofosu FA
    J Biol Chem; 1997 Jan; 272(3):1997-2004. PubMed ID: 8999892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
    Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A
    J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of recombinant hirudin on cytosolic Ca2+ concentrations using different platelet stimulators.
    Kirchmaier CM; Bellinger OK; Schulz B; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():121-6. PubMed ID: 1894187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.
    Huang Y; Zhang Y; Zhao B; Xu Q; Zhou X; Song H; Yu M; Mo W
    BMC Struct Biol; 2014 Dec; 14():26. PubMed ID: 25526801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positional effects of sulfation in hirudin and hirudin PA related anticoagulant peptides.
    Payne MH; Krstenansky JL; Yates MT; Mao SJ
    J Med Chem; 1991 Mar; 34(3):1184-7. PubMed ID: 2002458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.
    Li CQ; Vindigni A; Sadler JE; Wardell MR
    J Biol Chem; 2001 Mar; 276(9):6161-8. PubMed ID: 11024046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Domains specifying thrombin-receptor interaction.
    Vu TK; Wheaton VI; Hung DT; Charo I; Coughlin SR
    Nature; 1991 Oct; 353(6345):674-7. PubMed ID: 1717851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the thrombin-platelet reaction by hirudin.
    Hoffmann A; Markwardt F
    Haemostasis; 1984; 14(2):164-9. PubMed ID: 6735274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis.
    Yue SY; DiMaio J; Szewczuk Z; Purisima EO; Ni F; Konishi Y
    Protein Eng; 1992 Jan; 5(1):77-85. PubMed ID: 1631048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
    Chang JY; Ngai PK; Rink H; Dennis S; Schlaeppi JM
    FEBS Lett; 1990 Feb; 261(2):287-90. PubMed ID: 2107100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Basis for the reduced affinity of beta T- and gamma T-thrombin for hirudin.
    Stone SR; Hofsteenge J
    Biochemistry; 1991 Apr; 30(16):3950-5. PubMed ID: 2018764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.